Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV000004225 | SCV001367972 | likely pathogenic | Schizophrenia 4 | 2019-05-13 | criteria provided, single submitter | clinical testing | This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PS3,PM3, PP3, PP5. |
Invitae | RCV000004224 | SCV001728184 | benign | Proline dehydrogenase deficiency | 2024-01-29 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV000004224 | SCV002581197 | uncertain significance | Proline dehydrogenase deficiency | 2022-04-29 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000004224 | SCV004806537 | likely benign | Proline dehydrogenase deficiency | 2024-03-26 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000004224 | SCV000024390 | pathogenic | Proline dehydrogenase deficiency | 2005-03-01 | no assertion criteria provided | literature only | |
OMIM | RCV000004225 | SCV000024391 | risk factor | Schizophrenia 4 | 2005-03-01 | no assertion criteria provided | literature only |